Skip to content

    Multiple Sclerosis Health Center

    Font Size

    Epstein-Barr Virus Linked to MS

    Study Shows Common Virus May Help Trigger Multiple Sclerosis
    WebMD Health News
    Reviewed by Louise Chang, MD

    May 4, 2009 (Seattle) -- Infection with Epstein-Barr virus appears to raise the risk of developing multiple sclerosis (MS), Boston researchers report.

    The findings offer the strongest evidence to date implicating the virus as a trigger for the chronic progressive autoimmune disorder of the brain and spinal cord that affects more than 350,000 Americans, says Lily Jung, MD, medical director of the neurology clinic at the Swedish Neurology Institute in Seattle. Jung was not involved in the study.

    Almost everyone is infected with Epstein-Barr virus (EBV) by the time they reach adulthood. Infection early in childhood typically does not cause severe illness, although infection that occurs in adolescence often leads to mononucleosis.

    Researchers have searched for decades for a viral or bacterial agent that may trigger MS in people who are genetically susceptible. Epidemiology professor Alberto Ascherio, MD, DrPH, and colleagues at the Harvard School of Public Health in Boston have published several studies suggesting that the Epstein-Barr virus may be that agent.

    The new study shows "that people who are not infected with Epstein-Barr virus do not get MS," Ascherio tells WebMD. "All 100% of people who got MS in our study were infected with Epstein-Barr virus," he says.

    The findings were presented at the annual meeting of the American Academy of Neurology.

    MS Risk and Epstein-Barr Virus Antibodies

    For the study, the researchers were granted access to more than 7 million blood specimens stored in the Department of Defense Serum Repository. The U.S. military maintains service members' medical records in electronic databases.

    The researchers identified 305 service members who were diagnosed with MS plus had up to three blood samples taken prior to diagnosis. Researchers compared these blood specimens with samples from 610 people who did not develop MS but were similar in age, race, sex, and other characteristics to those who did.

    The initial blood sample tested negative for EBV-fighting antibodies in 10 (3.2%) of people who developed MS and 32 (5.3%) of people who didn't. Measuring antibodies, which are proteins produced by the body to fight specific infections, is one way to determine the intensity of infection.

    Today on WebMD

    nerve damage
    Learn how this disease affects the nervous system.
    woman applying lotion
    Ideas on how to boost your mood and self-esteem.
    woman pondering
    Get personalized treatment options.
    man with hand over eye
    Be on the lookout for these symptoms.
    brain scan
    worried woman
    neural fiber
    white blood cells
    sunlight in hands
    marijuana plant
    muscle spasm